CTD-O 6.25/20 Tablet
Marketer
Ipca Laboratories Ltd
Salt Composition
Olmesartan Medoxomil (20mg) + Chlorthalidone (6.25mg)
Overview CTD-O 6.25/20 Tablet
The dual-action tablet, CTD-O 6.25/20, effectively manages hypertension through a combined approach. Untreated high blood pressure significantly raises the risk of serious complications, including stroke, heart attack, and kidney disease. CTD-O 6.25/20 can be taken with or without food; dosage is individualized based on your response and health status. Consistent daily administration is crucial for optimal results, continuing as directed by your physician. This medication incorporates a diuretic, increasing urination; therefore, avoid ingestion within four hours of bedtime. Regular use is vital, even if feeling well, as hypertension often presents asymptomatically. Discontinuing treatment elevates the risk of cardiovascular events. Common side effects include dizziness, fatigue, nausea, diarrhea, headache, and hypotension. Increased urination is an expected effect of the chlorthalidone component, contributing to blood pressure control. While other side effects are possible, most are infrequent. Consult the patient information leaflet and inform your doctor about persistent or bothersome side effects; dosage adjustment or alternative medication may be considered. This medication is contraindicated during pregnancy and requires physician consultation if you have kidney, liver, cardiac, or diabetic conditions. Alcohol consumption can exacerbate hypotension and intensify side effects.
Uses of CTD-O 6.25/20 Tablet
Elevated arterial blood pressure
Major Benefits of CTD-O 6.25/20 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. CTD-O 6.25/20 Tablets can be administered with or without food, however, consistent timing is recommended.
Common Side effects of CTD-O 6.25/20 Tablet:
- Nausea
- Taste change
- Diarrhea
- Upset stomach
- Weakness
- Headache
- Increased blood uric acid
- Dizziness
- Increased blood lipid level
- Electrolyte imbalance
- Decreased blood pressure
- Urinary tract infection
- Renal dysfunction
- Sore throat
- Abnormal liver function tests
- Increased potassium level in blood
How to use CTD-O 6.25/20 Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. CTD-O 6.25/20 Tablets can be consumed with or without food, though consistent timing is recommended.
How CTD-O 6.25/20 Tablet works:
Each CTD-O 6.25/20 Tablet contains a dual-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of CTD-O 6.25/20 Tablets and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using CTD-O 6.25/20 tablets during pregnancy poses a confirmed risk to the fetus. Its prescription is therefore contraindicated except in rare, life-threatening circumstances where potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of CTD-O 6.25/20 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking CTD-O 6.25/20 Tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using CTD-O 6.25/20 Tablet, as dose modification may be necessary. Physician consultation is advised; this medication is generally unsuitable for such patients.
LiverCAUTION
Patients with hepatic impairment should use CTD-O 6.25/20 Tablet cautiously; dosage modification may be necessary. Consult a physician for guidance. CTD-O 6.25/20 Tablet is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take CTD-O 6.25/20 Tablet :
Should you forget a CTD-O 6.25/20 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About CTD-O 6.25/20 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |






